IGC
Igc Pharma Inc
AMEX · Pharmaceuticals
$0.25
+0.00 (+0.81%)
Open$0.25
Previous Close$0.25
Day High$0.26
Day Low$0.24
52W High$20.84
52W Low$9.04
Volume—
Avg Volume250.1K
Market Cap23.99M
P/E Ratio13.31
EPS$1.12
SectorPharmaceuticals
Analyst Ratings
Strong Buy
5 analysts
Price Target
+6,146.0% upside
Current
$0.25
$0.25
Target
$15.64
$15.64
$13.90
$15.64 avg
$22.29
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 13.24M | 13.95M | 13.36M |
| Net Income | 1.80M | 2.16M | 1.76M |
| Profit Margin | 13.6% | 15.5% | 13.2% |
| EBITDA | 3.50M | 3.52M | 3.64M |
| Free Cash Flow | 1.97M | 2.06M | 1.63M |
| Rev Growth | +11.8% | +17.1% | -6.7% |
| Debt/Equity | 0.72 | 0.52 | 0.61 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |